HomeNDC LookupRxCUI directory › RxCUI 197379

Atenolol 100 MG Oral Tablet — RxCUI 197379

RxNorm drug concept · Semantic clinical drug
RxCUI 197379 Semantic clinical drug · SCD ● Current RxNorm concept 59 FDA products 164 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197379
Official nameAtenolol 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped59
Package NDCs mapped164
Reported Medicaid activity (SDUD)765,671 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Atenolol: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Atenolol is mainly used for three things: lowering high blood pressure, managing chest pain from angina (narrowed heart arteries), and reducing the risk of dying after a heart atta...
  • Please don't stop atenolol suddenly — especially if you have any coronary artery disease, even if you don't know about it. Stopping abruptly has been linked to serious chest pain,...
  • Can I just stop taking atenolol if I feel fine?
  • The most common ones are feeling tired, a slower heart rate, dizziness, cold hands or feet, and occasionally nausea. Most are mild. The ones to call your doctor about are a very sl...
📖 Read our full Atenolol guide →

🕸️ Concept Web — How Atenolol 100 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Atenolol 100 MG Oral Tablet RxCUI 197379

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Atenolol 1202
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tenormin 152413
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Atenolol Oral Tablet 370619
    • Atenolol Oral Product 1154378
    • Atenolol Pill 1154379
    • Atenolol Oral Tablet [Tenormin] 367659
    • Tenormin Oral Product 1182019
    • Tenormin Pill 1182020
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Atenolol 100 MG SCDC · 315436
  • Atenolol Oral Tablet SCDF · 370619
  • Atenolol Oral Product SCDG · 1154378
  • Atenolol Pill SCDG · 1154379

Brand-Name Concepts

  • Atenolol 100 MG Oral Tablet [Tenormin] SBD · 201322
  • Atenolol 100 MG [Tenormin] SBDC · 565804
  • Atenolol Oral Tablet [Tenormin] SBDF · 367659
  • Tenormin Oral Product SBDG · 1182019
  • Tenormin Pill SBDG · 1182020
  • Tenormin BN · 152413

📦 FDA Products & Package NDCs

59 products · 164 package NDCs
164 package NDCs map to RxCUI 197379 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-0752-01 100 TABLET in 1 BOTTLE (0093-0752-01) Atenolol Teva Pharmaceuticals USA, Inc. 1995-02-22
00093-0752-10 1000 TABLET in 1 BOTTLE (0093-0752-10) Atenolol Teva Pharmaceuticals USA, Inc. 1995-02-22
00093-0753-01 100 TABLET in 1 BOTTLE (0093-0753-01) Atenolol Teva Pharmaceuticals USA, Inc. 1995-02-17
00093-0753-05 500 TABLET in 1 BOTTLE (0093-0753-05) Atenolol Teva Pharmaceuticals USA, Inc. 2007-10-23
00093-0787-01 100 TABLET in 1 BOTTLE (0093-0787-01) Atenolol Teva Pharmaceuticals USA, Inc. 2004-11-16
00093-0787-10 1000 TABLET in 1 BOTTLE (0093-0787-10) Atenolol Teva Pharmaceuticals USA, Inc. 2004-11-16
00378-0218-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-0218-01) Atenolol Mylan Pharmaceuticals Inc. 1999-06-17
00378-0218-10 1000 TABLET in 1 BOTTLE, PLASTIC (0378-0218-10) Atenolol Mylan Pharmaceuticals Inc. 1999-06-17
00378-0231-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-0231-01) Atenolol Mylan Pharmaceuticals Inc. 1992-01-24
00378-0231-10 1000 TABLET in 1 BOTTLE, PLASTIC (0378-0231-10) Atenolol Mylan Pharmaceuticals Inc. 1992-01-24
00378-0757-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-0757-01) Atenolol Mylan Pharmaceuticals Inc. 1992-01-24
00378-0757-10 1000 TABLET in 1 BOTTLE, PLASTIC (0378-0757-10) Atenolol Mylan Pharmaceuticals Inc. 1992-01-24
24979-0244-07 90 TABLET in 1 BOTTLE (24979-244-07) TENORMIN Upsher-Smith Laboratories, LLC 2024-08-01
24979-0245-07 90 TABLET in 1 BOTTLE (24979-245-07) TENORMIN Upsher-Smith Laboratories, LLC 2024-08-01
24979-0246-07 90 TABLET in 1 BOTTLE (24979-246-07) TENORMIN Upsher-Smith Laboratories, LLC 2024-08-01
29300-0410-01 100 TABLET in 1 BOTTLE (29300-410-01) Atenolol Unichem Pharmaceuticals (USA), Inc. 2020-01-06
29300-0410-05 500 TABLET in 1 BOTTLE (29300-410-05) Atenolol Unichem Pharmaceuticals (USA), Inc. 2020-01-06
29300-0410-10 1000 TABLET in 1 BOTTLE (29300-410-10) Atenolol Unichem Pharmaceuticals (USA), Inc. 2022-08-26
29300-0411-01 100 TABLET in 1 BOTTLE (29300-411-01) Atenolol Unichem Pharmaceuticals (USA), Inc. 2020-01-06
29300-0411-05 500 TABLET in 1 BOTTLE (29300-411-05) Atenolol Unichem Pharmaceuticals (USA), Inc. 2020-01-06
29300-0411-10 1000 TABLET in 1 BOTTLE (29300-411-10) Atenolol Unichem Pharmaceuticals (USA), Inc. 2022-08-26
29300-0412-01 100 TABLET in 1 BOTTLE (29300-412-01) Atenolol Unichem Pharmaceuticals (USA), Inc. 2020-01-06
29300-0412-05 500 TABLET in 1 BOTTLE (29300-412-05) Atenolol Unichem Pharmaceuticals (USA), Inc. 2020-01-06
29300-0412-10 1000 TABLET in 1 BOTTLE (29300-412-10) Atenolol Unichem Pharmaceuticals (USA), Inc. 2022-08-26
43353-0834-30 30 TABLET in 1 BOTTLE, PLASTIC (43353-834-30) Atenolol Aphena Pharma Solutions - Tennessee, LLC 2014-12-27
43353-0834-45 45 TABLET in 1 BOTTLE, PLASTIC (43353-834-45) Atenolol Aphena Pharma Solutions - Tennessee, LLC 2014-11-18
43353-0834-60 90 TABLET in 1 BOTTLE, PLASTIC (43353-834-60) Atenolol Aphena Pharma Solutions - Tennessee, LLC 2014-12-04
43353-0834-73 135 TABLET in 1 BOTTLE, PLASTIC (43353-834-73) Atenolol Aphena Pharma Solutions - Tennessee, LLC 2014-12-04
43353-0834-80 180 TABLET in 1 BOTTLE, PLASTIC (43353-834-80) Atenolol Aphena Pharma Solutions - Tennessee, LLC 2014-11-18
43353-0986-60 90 TABLET in 1 BOTTLE, PLASTIC (43353-986-60) Atenolol Aphena Pharma Solutions - Tennessee, LLC 2014-12-04
50090-5738-00 30 TABLET in 1 BOTTLE (50090-5738-0) Atenolol A-S Medication Solutions 2021-09-29
50090-5738-03 60 TABLET in 1 BOTTLE (50090-5738-3) Atenolol A-S Medication Solutions 2021-09-29
50090-5738-05 90 TABLET in 1 BOTTLE (50090-5738-5) Atenolol A-S Medication Solutions 2021-09-29
50090-6311-00 30 TABLET in 1 BOTTLE (50090-6311-0) Atenolol A-S Medication Solutions 2023-01-05
50090-6311-03 60 TABLET in 1 BOTTLE (50090-6311-3) Atenolol A-S Medication Solutions 2023-01-05
50090-6311-05 90 TABLET in 1 BOTTLE (50090-6311-5) Atenolol A-S Medication Solutions 2023-01-05
51079-0684-20 100 BLISTER PACK in 1 CARTON (51079-684-20) / 1 TABLET in 1... Atenolol Mylan Institutional Inc. 1997-07-24
51079-0685-20 100 BLISTER PACK in 1 CARTON (51079-685-20) / 1 TABLET in 1... Atenolol Mylan Institutional Inc. 1997-07-23
51079-0759-20 100 BLISTER PACK in 1 CARTON (51079-759-20) / 1 TABLET in 1... Atenolol Mylan Institutional Inc. 1999-06-16
51655-0104-26 90 TABLET in 1 BOTTLE, PLASTIC (51655-104-26) Atenolol Northwind Health Company, LLC 2022-09-09
51655-0104-52 30 TABLET in 1 BOTTLE, PLASTIC (51655-104-52) Atenolol Northwind Health Company, LLC 2023-10-19
51655-0736-26 90 TABLET in 1 BOTTLE, PLASTIC (51655-736-26) Atenolol Northwind Health Company, LLC 2022-01-28
51655-0736-52 30 TABLET in 1 BOTTLE, PLASTIC (51655-736-52) Atenolol Northwind Health Company, LLC 2021-06-17
52427-0430-90 90 TABLET in 1 BOTTLE (52427-430-90) TENORMIN Almatica Pharma LLC 2015-04-15
52427-0431-90 90 TABLET in 1 BOTTLE (52427-431-90) TENORMIN Almatica Pharma LLC 2015-04-15
60429-0025-10 1000 TABLET in 1 BOTTLE, PLASTIC (60429-025-10) Atenolol Golden State Medical Supply, Inc. 2014-02-20
60429-0025-90 90 TABLET in 1 BOTTLE, PLASTIC (60429-025-90) Atenolol Golden State Medical Supply, Inc. 2014-02-20
60429-0026-10 1000 TABLET in 1 BOTTLE, PLASTIC (60429-026-10) Atenolol Golden State Medical Supply, Inc. 2014-02-20
60429-0026-90 90 TABLET in 1 BOTTLE, PLASTIC (60429-026-90) Atenolol Golden State Medical Supply, Inc. 2014-02-20
60429-0027-10 1000 TABLET in 1 BOTTLE, PLASTIC (60429-027-10) Atenolol Golden State Medical Supply, Inc. 2014-02-20
Observed labelers: Bryant Ranch Prepack (29) · Zydus Lifesciences Limited (15) · Zydus Pharmaceuticals USA Inc. (15) · ASCLEMED USA INC. (12) · Ipca Laboratories Limited (9) · Unichem Pharmaceuticals (USA), Inc. (9) · +19 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.